Timothy Barabeto Support HeartFlows Global Reach as Part of its Board
healthcaretechoutlook

Timothy Barabeto Support HeartFlows Global Reach as Part of its Board

Healthcare Tech Outlook | Thursday, February 17, 2022

Timothy Barabe has been appointed to HeartFlow's Board of Directors, where his expertise in the field will help the board enter its next chapter of expansion.

Fremont, CA: "We are honored to have an accomplished leader like Tim join the HeartFlow Board," states William C. Weldon, Chairman of the Board of Directors, HeartFlow. "Tim's background and expertise in financial strategy, operations and stewardship will add important perspectives to the Board as we enter our next phase of growth." Timothy Barabe has been appointed to the Board of Directors of HeartFlow Holding, Inc., the leader in redefining precision heart care.

Mr. Barabe has worked in the life sciences business for over 30 years in a variety of financial and strategic capacities. Mr. Barabe was most recently the chief financial officer and executive vice president of Affymetrix Inc., where he oversaw the company's financial, treasury, investor relations, and information technology departments. He was previously the company's senior vice president and chief financial officer, where he worked with the executive team to steer the company's financial strategy and operations. He worked with Novartis AG for more than 20 years in senior worldwide executive roles in finance, general management, and strategic planning. He served as the Sandoz Generics Business Unit's chief financial officer, the CIBA Vision Corporation Specialty Lens Business Franchise's president, and CIBA Vision Corporation's group vice president and chief financial officer.

Mr. Barabe holds a bachelor's degree in finance from the University of Massachusetts (Amherst) and a master's degree in business administration from the University of Chicago. He is currently a board member of Selecta Biosciences, Inc. and the chair of the Audit Committee, as well as a board member of Vigilant Biosciences, a privately held medical device firm. Veeva Systems, Inc., ArQule, Opexa Therapeutics, Autonomous Technologies, and BioCure, Inc. were among the companies he formerly sat on the boards of. Tim is an enthusiastic philanthropist who is interested in a variety of charity projects. From 2014 to 2020, he sat on the board of Project Open Hand, a San Francisco-based non-profit focusing on distributing nutritional meals to needy people.

"I am thrilled to join the Board of Directors for HeartFlow as the company is at a key inflection point in its growth trajectory," comments Barabe. "I look forward to leveraging my experience and working with the team to make HeartFlows game-changing technology broadly available to more patients worldwide."

Weekly Brief